Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-09-05
1992-01-14
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544283, 544284, 544285, 544286, 544287, 544289, A61K 31505, C07D23990
Patent
active
050811240
ABSTRACT:
A quinazoline of the formula: ##STR1## wherein R.sup.1 is alkyl, cycloalkyl, alkenyl, alkynyl, alkoxy, alkylthio, aryl, aryloxy, arylalkyl, halogeno, hydroxy, mercapto, pyridylthio, pyrimidinylthio, or substituted alkyl or alkoxy;
REFERENCES:
patent: 3472851 (1969-10-01), Davoll
patent: 4447608 (1984-05-01), Jones et al.
"Eur. J. Cancer Oncol.", vol. 24, No. 4, 1988, pp. 733-736.
"Eur. J. Cancer Oncol.", vol. 24, No. 4, 1988, pp. 769-775.
"Journal of Hepatology", 1987, 4:349-356; Basserdine, et al.
"Journal of Clinical Oncology", vol. 4, No. 8, 1986, pp. 1245-1252.
Imperial Chemical Industries plc
Ivy C. Warren
Turnipseed James H.
LandOfFree
Method of producing antitumor effect using quinazolin-4-one deri does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of producing antitumor effect using quinazolin-4-one deri, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of producing antitumor effect using quinazolin-4-one deri will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-541804